Global Disease Control and Prevention Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.
According to our (Global Info Research) latest study, the global Disease Control and Prevention Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Disease Control and Prevention Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Disease Control and Prevention Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Disease Control and Prevention Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Disease Control and Prevention Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Disease Control and Prevention Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Disease Control and Prevention Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Disease Control and Prevention Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck & Co., Inc, Pfizer, Sanofi and AstraZeneca PLC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Disease Control and Prevention Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Disease Control and Prevention Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Disease Control and Prevention Vaccine, with price, sales, revenue and global market share of Disease Control and Prevention Vaccine from 2018 to 2023.
Chapter 3, the Disease Control and Prevention Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Disease Control and Prevention Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Disease Control and Prevention Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Disease Control and Prevention Vaccine.
Chapter 14 and 15, to describe Disease Control and Prevention Vaccine sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Disease Control and Prevention Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Disease Control and Prevention Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Disease Control and Prevention Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Disease Control and Prevention Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Disease Control and Prevention Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Disease Control and Prevention Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Disease Control and Prevention Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Disease Control and Prevention Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck & Co., Inc, Pfizer, Sanofi and AstraZeneca PLC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Disease Control and Prevention Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Live-Attenuated
- Inactivated
- Recombinant Sub Unit and Toxoid
- Pediatric Vaccine
- Adult Vaccine
- GSK
- Merck & Co., Inc
- Pfizer
- Sanofi
- AstraZeneca PLC
- Sinovac Biotech Ltd
- Astellas Pharma Inc
- Serum Institute of India Pvt. Ltd
- Daiichi Sankyo
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Disease Control and Prevention Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Disease Control and Prevention Vaccine, with price, sales, revenue and global market share of Disease Control and Prevention Vaccine from 2018 to 2023.
Chapter 3, the Disease Control and Prevention Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Disease Control and Prevention Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Disease Control and Prevention Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Disease Control and Prevention Vaccine.
Chapter 14 and 15, to describe Disease Control and Prevention Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Disease Control and Prevention Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Disease Control and Prevention Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Live-Attenuated
1.3.3 Inactivated
1.3.4 Recombinant Sub Unit and Toxoid
1.4 Market Analysis by Application
1.4.1 Overview: Global Disease Control and Prevention Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pediatric Vaccine
1.4.3 Adult Vaccine
1.5 Global Disease Control and Prevention Vaccine Market Size & Forecast
1.5.1 Global Disease Control and Prevention Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Disease Control and Prevention Vaccine Sales Quantity (2018-2029)
1.5.3 Global Disease Control and Prevention Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Disease Control and Prevention Vaccine Product and Services
2.1.4 GSK Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GSK Recent Developments/Updates
2.2 Merck & Co., Inc
2.2.1 Merck & Co., Inc Details
2.2.2 Merck & Co., Inc Major Business
2.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Product and Services
2.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck & Co., Inc Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Disease Control and Prevention Vaccine Product and Services
2.3.4 Pfizer Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Disease Control and Prevention Vaccine Product and Services
2.4.4 Sanofi Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sanofi Recent Developments/Updates
2.5 AstraZeneca PLC
2.5.1 AstraZeneca PLC Details
2.5.2 AstraZeneca PLC Major Business
2.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Product and Services
2.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca PLC Recent Developments/Updates
2.6 Sinovac Biotech Ltd
2.6.1 Sinovac Biotech Ltd Details
2.6.2 Sinovac Biotech Ltd Major Business
2.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product and Services
2.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sinovac Biotech Ltd Recent Developments/Updates
2.7 Astellas Pharma Inc
2.7.1 Astellas Pharma Inc Details
2.7.2 Astellas Pharma Inc Major Business
2.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Product and Services
2.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Astellas Pharma Inc Recent Developments/Updates
2.8 Serum Institute of India Pvt. Ltd
2.8.1 Serum Institute of India Pvt. Ltd Details
2.8.2 Serum Institute of India Pvt. Ltd Major Business
2.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product and Services
2.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Serum Institute of India Pvt. Ltd Recent Developments/Updates
2.9 Daiichi Sankyo
2.9.1 Daiichi Sankyo Details
2.9.2 Daiichi Sankyo Major Business
2.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Product and Services
2.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Daiichi Sankyo Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DISEASE CONTROL AND PREVENTION VACCINE BY MANUFACTURER
3.1 Global Disease Control and Prevention Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Disease Control and Prevention Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Disease Control and Prevention Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Disease Control and Prevention Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Disease Control and Prevention Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Disease Control and Prevention Vaccine Manufacturer Market Share in 2022
3.5 Disease Control and Prevention Vaccine Market: Overall Company Footprint Analysis
3.5.1 Disease Control and Prevention Vaccine Market: Region Footprint
3.5.2 Disease Control and Prevention Vaccine Market: Company Product Type Footprint
3.5.3 Disease Control and Prevention Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Disease Control and Prevention Vaccine Market Size by Region
4.1.1 Global Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Disease Control and Prevention Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Disease Control and Prevention Vaccine Average Price by Region (2018-2029)
4.2 North America Disease Control and Prevention Vaccine Consumption Value (2018-2029)
4.3 Europe Disease Control and Prevention Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Disease Control and Prevention Vaccine Consumption Value (2018-2029)
4.5 South America Disease Control and Prevention Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Disease Control and Prevention Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Disease Control and Prevention Vaccine Consumption Value by Type (2018-2029)
5.3 Global Disease Control and Prevention Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Disease Control and Prevention Vaccine Consumption Value by Application (2018-2029)
6.3 Global Disease Control and Prevention Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Disease Control and Prevention Vaccine Market Size by Country
7.3.1 North America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Disease Control and Prevention Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Disease Control and Prevention Vaccine Market Size by Country
8.3.1 Europe Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Disease Control and Prevention Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region
9.3.1 Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Disease Control and Prevention Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Disease Control and Prevention Vaccine Market Size by Country
10.3.1 South America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Disease Control and Prevention Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country
11.3.1 Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Disease Control and Prevention Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Disease Control and Prevention Vaccine Market Drivers
12.2 Disease Control and Prevention Vaccine Market Restraints
12.3 Disease Control and Prevention Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Disease Control and Prevention Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Disease Control and Prevention Vaccine
13.3 Disease Control and Prevention Vaccine Production Process
13.4 Disease Control and Prevention Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Disease Control and Prevention Vaccine Typical Distributors
14.3 Disease Control and Prevention Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Disease Control and Prevention Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Disease Control and Prevention Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Live-Attenuated
1.3.3 Inactivated
1.3.4 Recombinant Sub Unit and Toxoid
1.4 Market Analysis by Application
1.4.1 Overview: Global Disease Control and Prevention Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pediatric Vaccine
1.4.3 Adult Vaccine
1.5 Global Disease Control and Prevention Vaccine Market Size & Forecast
1.5.1 Global Disease Control and Prevention Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Disease Control and Prevention Vaccine Sales Quantity (2018-2029)
1.5.3 Global Disease Control and Prevention Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Disease Control and Prevention Vaccine Product and Services
2.1.4 GSK Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GSK Recent Developments/Updates
2.2 Merck & Co., Inc
2.2.1 Merck & Co., Inc Details
2.2.2 Merck & Co., Inc Major Business
2.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Product and Services
2.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck & Co., Inc Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Disease Control and Prevention Vaccine Product and Services
2.3.4 Pfizer Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Disease Control and Prevention Vaccine Product and Services
2.4.4 Sanofi Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sanofi Recent Developments/Updates
2.5 AstraZeneca PLC
2.5.1 AstraZeneca PLC Details
2.5.2 AstraZeneca PLC Major Business
2.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Product and Services
2.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca PLC Recent Developments/Updates
2.6 Sinovac Biotech Ltd
2.6.1 Sinovac Biotech Ltd Details
2.6.2 Sinovac Biotech Ltd Major Business
2.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product and Services
2.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sinovac Biotech Ltd Recent Developments/Updates
2.7 Astellas Pharma Inc
2.7.1 Astellas Pharma Inc Details
2.7.2 Astellas Pharma Inc Major Business
2.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Product and Services
2.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Astellas Pharma Inc Recent Developments/Updates
2.8 Serum Institute of India Pvt. Ltd
2.8.1 Serum Institute of India Pvt. Ltd Details
2.8.2 Serum Institute of India Pvt. Ltd Major Business
2.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product and Services
2.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Serum Institute of India Pvt. Ltd Recent Developments/Updates
2.9 Daiichi Sankyo
2.9.1 Daiichi Sankyo Details
2.9.2 Daiichi Sankyo Major Business
2.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Product and Services
2.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Daiichi Sankyo Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DISEASE CONTROL AND PREVENTION VACCINE BY MANUFACTURER
3.1 Global Disease Control and Prevention Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Disease Control and Prevention Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Disease Control and Prevention Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Disease Control and Prevention Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Disease Control and Prevention Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Disease Control and Prevention Vaccine Manufacturer Market Share in 2022
3.5 Disease Control and Prevention Vaccine Market: Overall Company Footprint Analysis
3.5.1 Disease Control and Prevention Vaccine Market: Region Footprint
3.5.2 Disease Control and Prevention Vaccine Market: Company Product Type Footprint
3.5.3 Disease Control and Prevention Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Disease Control and Prevention Vaccine Market Size by Region
4.1.1 Global Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Disease Control and Prevention Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Disease Control and Prevention Vaccine Average Price by Region (2018-2029)
4.2 North America Disease Control and Prevention Vaccine Consumption Value (2018-2029)
4.3 Europe Disease Control and Prevention Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Disease Control and Prevention Vaccine Consumption Value (2018-2029)
4.5 South America Disease Control and Prevention Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Disease Control and Prevention Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Disease Control and Prevention Vaccine Consumption Value by Type (2018-2029)
5.3 Global Disease Control and Prevention Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Disease Control and Prevention Vaccine Consumption Value by Application (2018-2029)
6.3 Global Disease Control and Prevention Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Disease Control and Prevention Vaccine Market Size by Country
7.3.1 North America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Disease Control and Prevention Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Disease Control and Prevention Vaccine Market Size by Country
8.3.1 Europe Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Disease Control and Prevention Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region
9.3.1 Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Disease Control and Prevention Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Disease Control and Prevention Vaccine Market Size by Country
10.3.1 South America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Disease Control and Prevention Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country
11.3.1 Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Disease Control and Prevention Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Disease Control and Prevention Vaccine Market Drivers
12.2 Disease Control and Prevention Vaccine Market Restraints
12.3 Disease Control and Prevention Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Disease Control and Prevention Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Disease Control and Prevention Vaccine
13.3 Disease Control and Prevention Vaccine Production Process
13.4 Disease Control and Prevention Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Disease Control and Prevention Vaccine Typical Distributors
14.3 Disease Control and Prevention Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Disease Control and Prevention Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Disease Control and Prevention Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Disease Control and Prevention Vaccine Product and Services
Table 6. GSK Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GSK Recent Developments/Updates
Table 8. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 9. Merck & Co., Inc Major Business
Table 10. Merck & Co., Inc Disease Control and Prevention Vaccine Product and Services
Table 11. Merck & Co., Inc Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck & Co., Inc Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Disease Control and Prevention Vaccine Product and Services
Table 16. Pfizer Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Disease Control and Prevention Vaccine Product and Services
Table 21. Sanofi Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sanofi Recent Developments/Updates
Table 23. AstraZeneca PLC Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca PLC Major Business
Table 25. AstraZeneca PLC Disease Control and Prevention Vaccine Product and Services
Table 26. AstraZeneca PLC Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca PLC Recent Developments/Updates
Table 28. Sinovac Biotech Ltd Basic Information, Manufacturing Base and Competitors
Table 29. Sinovac Biotech Ltd Major Business
Table 30. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product and Services
Table 31. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sinovac Biotech Ltd Recent Developments/Updates
Table 33. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 34. Astellas Pharma Inc Major Business
Table 35. Astellas Pharma Inc Disease Control and Prevention Vaccine Product and Services
Table 36. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Astellas Pharma Inc Recent Developments/Updates
Table 38. Serum Institute of India Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Serum Institute of India Pvt. Ltd Major Business
Table 40. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product and Services
Table 41. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Serum Institute of India Pvt. Ltd Recent Developments/Updates
Table 43. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 44. Daiichi Sankyo Major Business
Table 45. Daiichi Sankyo Disease Control and Prevention Vaccine Product and Services
Table 46. Daiichi Sankyo Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Daiichi Sankyo Recent Developments/Updates
Table 48. Global Disease Control and Prevention Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Disease Control and Prevention Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Disease Control and Prevention Vaccine Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 51. Market Position of Manufacturers in Disease Control and Prevention Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Disease Control and Prevention Vaccine Production Site of Key Manufacturer
Table 53. Disease Control and Prevention Vaccine Market: Company Product Type Footprint
Table 54. Disease Control and Prevention Vaccine Market: Company Product Application Footprint
Table 55. Disease Control and Prevention Vaccine New Market Entrants and Barriers to Market Entry
Table 56. Disease Control and Prevention Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Disease Control and Prevention Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Disease Control and Prevention Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Disease Control and Prevention Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Disease Control and Prevention Vaccine Average Price by Region (2018-2023) & (USD/Unit)
Table 62. Global Disease Control and Prevention Vaccine Average Price by Region (2024-2029) & (USD/Unit)
Table 63. Global Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Disease Control and Prevention Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Disease Control and Prevention Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Disease Control and Prevention Vaccine Average Price by Type (2018-2023) & (USD/Unit)
Table 68. Global Disease Control and Prevention Vaccine Average Price by Type (2024-2029) & (USD/Unit)
Table 69. Global Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Disease Control and Prevention Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Disease Control and Prevention Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Disease Control and Prevention Vaccine Average Price by Application (2018-2023) & (USD/Unit)
Table 74. Global Disease Control and Prevention Vaccine Average Price by Application (2024-2029) & (USD/Unit)
Table 75. North America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Disease Control and Prevention Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Disease Control and Prevention Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Disease Control and Prevention Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Disease Control and Prevention Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Disease Control and Prevention Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Disease Control and Prevention Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Disease Control and Prevention Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Disease Control and Prevention Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Disease Control and Prevention Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Disease Control and Prevention Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Disease Control and Prevention Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Disease Control and Prevention Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Disease Control and Prevention Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Disease Control and Prevention Vaccine Raw Material
Table 116. Key Manufacturers of Disease Control and Prevention Vaccine Raw Materials
Table 117. Disease Control and Prevention Vaccine Typical Distributors
Table 118. Disease Control and Prevention Vaccine Typical Customers
Table 1. Global Disease Control and Prevention Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Disease Control and Prevention Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Disease Control and Prevention Vaccine Product and Services
Table 6. GSK Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GSK Recent Developments/Updates
Table 8. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 9. Merck & Co., Inc Major Business
Table 10. Merck & Co., Inc Disease Control and Prevention Vaccine Product and Services
Table 11. Merck & Co., Inc Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck & Co., Inc Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Disease Control and Prevention Vaccine Product and Services
Table 16. Pfizer Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Disease Control and Prevention Vaccine Product and Services
Table 21. Sanofi Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sanofi Recent Developments/Updates
Table 23. AstraZeneca PLC Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca PLC Major Business
Table 25. AstraZeneca PLC Disease Control and Prevention Vaccine Product and Services
Table 26. AstraZeneca PLC Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca PLC Recent Developments/Updates
Table 28. Sinovac Biotech Ltd Basic Information, Manufacturing Base and Competitors
Table 29. Sinovac Biotech Ltd Major Business
Table 30. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product and Services
Table 31. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sinovac Biotech Ltd Recent Developments/Updates
Table 33. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 34. Astellas Pharma Inc Major Business
Table 35. Astellas Pharma Inc Disease Control and Prevention Vaccine Product and Services
Table 36. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Astellas Pharma Inc Recent Developments/Updates
Table 38. Serum Institute of India Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Serum Institute of India Pvt. Ltd Major Business
Table 40. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product and Services
Table 41. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Serum Institute of India Pvt. Ltd Recent Developments/Updates
Table 43. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 44. Daiichi Sankyo Major Business
Table 45. Daiichi Sankyo Disease Control and Prevention Vaccine Product and Services
Table 46. Daiichi Sankyo Disease Control and Prevention Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Daiichi Sankyo Recent Developments/Updates
Table 48. Global Disease Control and Prevention Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Disease Control and Prevention Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Disease Control and Prevention Vaccine Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 51. Market Position of Manufacturers in Disease Control and Prevention Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Disease Control and Prevention Vaccine Production Site of Key Manufacturer
Table 53. Disease Control and Prevention Vaccine Market: Company Product Type Footprint
Table 54. Disease Control and Prevention Vaccine Market: Company Product Application Footprint
Table 55. Disease Control and Prevention Vaccine New Market Entrants and Barriers to Market Entry
Table 56. Disease Control and Prevention Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Disease Control and Prevention Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Disease Control and Prevention Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Disease Control and Prevention Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Disease Control and Prevention Vaccine Average Price by Region (2018-2023) & (USD/Unit)
Table 62. Global Disease Control and Prevention Vaccine Average Price by Region (2024-2029) & (USD/Unit)
Table 63. Global Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Disease Control and Prevention Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Disease Control and Prevention Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Disease Control and Prevention Vaccine Average Price by Type (2018-2023) & (USD/Unit)
Table 68. Global Disease Control and Prevention Vaccine Average Price by Type (2024-2029) & (USD/Unit)
Table 69. Global Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Disease Control and Prevention Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Disease Control and Prevention Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Disease Control and Prevention Vaccine Average Price by Application (2018-2023) & (USD/Unit)
Table 74. Global Disease Control and Prevention Vaccine Average Price by Application (2024-2029) & (USD/Unit)
Table 75. North America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Disease Control and Prevention Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Disease Control and Prevention Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Disease Control and Prevention Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Disease Control and Prevention Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Disease Control and Prevention Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Disease Control and Prevention Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Disease Control and Prevention Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Disease Control and Prevention Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Disease Control and Prevention Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Disease Control and Prevention Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Disease Control and Prevention Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Disease Control and Prevention Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Disease Control and Prevention Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Disease Control and Prevention Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Disease Control and Prevention Vaccine Raw Material
Table 116. Key Manufacturers of Disease Control and Prevention Vaccine Raw Materials
Table 117. Disease Control and Prevention Vaccine Typical Distributors
Table 118. Disease Control and Prevention Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Disease Control and Prevention Vaccine Picture
Figure 2. Global Disease Control and Prevention Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Live-Attenuated Examples
Figure 5. Inactivated Examples
Figure 6. Recombinant Sub Unit and Toxoid Examples
Figure 7. Global Disease Control and Prevention Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Pediatric Vaccine Examples
Figure 10. Adult Vaccine Examples
Figure 11. Global Disease Control and Prevention Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Disease Control and Prevention Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Disease Control and Prevention Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Disease Control and Prevention Vaccine Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Disease Control and Prevention Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Disease Control and Prevention Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Disease Control and Prevention Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Disease Control and Prevention Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Disease Control and Prevention Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Disease Control and Prevention Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Disease Control and Prevention Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Disease Control and Prevention Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Disease Control and Prevention Vaccine Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Disease Control and Prevention Vaccine Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Disease Control and Prevention Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Disease Control and Prevention Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Disease Control and Prevention Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Disease Control and Prevention Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Disease Control and Prevention Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Disease Control and Prevention Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Disease Control and Prevention Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Disease Control and Prevention Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Disease Control and Prevention Vaccine Market Drivers
Figure 74. Disease Control and Prevention Vaccine Market Restraints
Figure 75. Disease Control and Prevention Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Disease Control and Prevention Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Disease Control and Prevention Vaccine
Figure 79. Disease Control and Prevention Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Disease Control and Prevention Vaccine Picture
Figure 2. Global Disease Control and Prevention Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Live-Attenuated Examples
Figure 5. Inactivated Examples
Figure 6. Recombinant Sub Unit and Toxoid Examples
Figure 7. Global Disease Control and Prevention Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Pediatric Vaccine Examples
Figure 10. Adult Vaccine Examples
Figure 11. Global Disease Control and Prevention Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Disease Control and Prevention Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Disease Control and Prevention Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Disease Control and Prevention Vaccine Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Disease Control and Prevention Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Disease Control and Prevention Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Disease Control and Prevention Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Disease Control and Prevention Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Disease Control and Prevention Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Disease Control and Prevention Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Disease Control and Prevention Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Disease Control and Prevention Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Disease Control and Prevention Vaccine Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Disease Control and Prevention Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Disease Control and Prevention Vaccine Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Disease Control and Prevention Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Disease Control and Prevention Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Disease Control and Prevention Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Disease Control and Prevention Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Disease Control and Prevention Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Disease Control and Prevention Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Disease Control and Prevention Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Disease Control and Prevention Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Disease Control and Prevention Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Disease Control and Prevention Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Disease Control and Prevention Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Disease Control and Prevention Vaccine Market Drivers
Figure 74. Disease Control and Prevention Vaccine Market Restraints
Figure 75. Disease Control and Prevention Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Disease Control and Prevention Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Disease Control and Prevention Vaccine
Figure 79. Disease Control and Prevention Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
